Biomeme

Biomeme is a biotech company in Philadelphia, United States, founded in 2012.

Mobile CBRN Biodefense & Point-of-Care Diagnostics

Employees
51–200
Founded
2012

About

Biomeme is a Philadelphia, Pennsylvania biotechnology company founded in 2012 that builds mobile molecular testing platforms. Its mission is to decentralize molecular diagnostics, putting laboratory-grade testing into the hands of the people who need answers most, wherever they are. Biomeme was founded with the simple premise of empowering anyone, anywhere, to understand the biological world, and its groundbreaking mobile molecular testing platform has offered clients elegant solutions to some very complex problems as it leverages expert knowledge of Earth's smallest life forms to address Earth's biggest health challenges.

Summary

It lists 51–200 employees.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Biomeme on Indexed.vc
<a href="https://indexed.vc/companies/biomeme"><img src="https://indexed.vc/api/badge/company/biomeme" alt="Biomeme on Indexed.vc" width="260" height="76" /></a>